Like most life sciences companies, Monsanto’s business relies on continuous innovation and disruption. But despite worldwide growth, it can be difficult to maintain a pace of constant innovation and repeated technological advances, especially for large, global enterprises traditionally slower to react to market changes. Monsanto is tackling that challenge by collaborating with startups to drive its digital transformation.
Life sciences and pharmaceutical executives are optimistic about the possibilities for growth in the global economy, but they’re less confident about their own businesses, according to the 2018 PricewaterhouseCoopers global CEO survey. Of the 70 life sciences and pharmaceutical CEOs surveyed, “46 percent are very confident about their company’s prospects for revenue growth over the next  months — a drop from last year’s survey, when 63 percent reported being ‘very confident.’”
Read More from This Article: How Monsanto leverages startups to catalyze transformation